JJ Kinahan is Senior Vice President, Head of Retail Expansion and Alternative Investment Products at Cboe Global Markets, Inc. (Cboe).
Key Takeaways:
What might a day of trading without Nvidia in the spotlight look like? We may not know for some time, but Wednesday’s mixed session might have offered a glimpse of what happens when investors look beyond the chipmaker for direction.
Despite better-than-expected earnings and upbeat forward guidance, Nvidia shares could not hold on to early gains, suggesting the jury is still out on Nvidia’s future. More on that later.
Many technology and semiconductor stocks still struggled as investors appeared to grow more selective about where they park their investments. Still, the Nasdaq Composite rose 0.42%, snapping its four-session losing streak.
Retailers rallied after Target and TJX reported better-than-expected sales and raised full-year guidance, perhaps offering some reassurance about holiday spending. The S&P 500 Index hovered near the flatline before finishing lower by 0.23%, extending its losing streak to five consecutive trading days.
The Dow Jones Industrial Average (DJIA) fared worse, closing lower by 1.11%, also marking its fifth consecutive decline as healthcare dragged on the blue-chip index. UnitedHealth was the biggest culprit, falling 10.2%, after the government proposed expanding Medicare Advantage audits, potentially exposing the insurer to billions of dollars in repayment obligations. UnitedHealth operates the largest Medicare Advantage plans in the U.S. Humana—which is not included in the DJIA —also retreated sharply, falling 13%.
Volatility eased but remained elevated. The Cboe Volatility Index® (VIX® Index) fell to about 24.6, but still hovers uncomfortably above the 20 level typically associated with calm.
Concerns about higher interest rates also intensified today. Consider a Dec. 9 rate hike a near certainty, given the Federal Reserve’s October meeting minutes, which reflected a decidedly hawkish tone. Nearly all policymakers agreed that further tightening “would likely be appropriate” to return inflation to the Fed’s 2% goal. Since then, inflation concerns have persisted.
Fed Governor Christopher Waller added to the hawkish rhetoric, telling CNBC the Fed may have to “shock people” with a 50-basis-point increase he has been promoting.
The market has largely been pricing in a 25-basis-point hike for some time, but Waller’s comments coupled with Fed minutes put the odds of a more aggressive half-point on the charts, according to the FedWatch barometer. It’s highly unlikely that will happen, but the question now looks to be how much more aggressive the Fed might have to be in 2027.
Back to Nvidia, which opened to the upside after Tuesday’s report, but lost that mojo to finish nearly 3% lower. Nvidia’s share price has fallen more than 30% in the last month.
Nvidia’s third-quarter results looked remarkable as did its outlook, which reflected high demand for artificial intelligence (AI) chips that the company said continues to exceed supply. The results and guidance suggest the chipmaker has had an amazing run. But what happens after that? Who is the next leader?
The leadership question is now front and center. Nvidia’s board is investigating former Chief Executive Jensen Huang’s extramarital affairs and other actions while the Justice and Commerce departments are taking a closer look at Singapore-based Megaspeed over potential China export violations. The Securities and Exchange Commission (SEC) is reportedly probing as well. All this scrutiny could complicate contracts going forward.
As a result, volatility is likely to remain a bigger part of the Nvidia story. The options market is pricing in an expected move in either direction of almost $23. It may remain an extraordinary company overall but the leadership question could weigh on it for some time. Those are the things investors need to consider as they look beyond the latest earnings report and determine what comes next for the AI trade.
Moving to Anthropic, a number of published reports said the Claude maker has priced its initial public offering (IPO) at $83 per share with an expectation of 825 million shares in a deal that’s said to be six to seven times oversubscribed. That puts the offering at roughly $68.5 billion for a $1.5 trillion valuation. Anthropic is slated to trade under the ticker ANT tomorrow, which may be the focus of tomorrow’s session.
Happy Trading!
© 2026 Cboe Exchange, Inc. All rights reserved.
The information provided is for general education and information purposes only. No statement provided should be construed as a recommendation to buy or sell a security, future, financial instrument, investment fund, or other investment product (collectively, a “financial product”), or to provide investment advice.